The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Open accessAbstract
Objectives CD19-targeting chimeric antigen receptor (CAR) T-cell therapy can induce long-term drug-free remission in patients with autoimmune diseases (AIDs). The efficacy of CD19-CAR T-cell therapy is presumably based on deep tissue depletion of B cells; however, such effect has not been proven in humans in vivo. Methods Sequential ultrasound-guided inguinal lymph node biopsies were performed at baseline and after CD19-CAR T-cell therapy in patients with AIDs. Results were compared with lymph node biopsies from rituximab (RTX)-treated AID patients with absence of peripheral B cells. Conventional and immunohistochemistry staining were performed on lymph node tissue to assess architecture as well the number of B cells, follicular dendritic cells (FDCs), plasma cells, T cells and macrophages. Results Sequential lymph node biopsies were analysed from five patients with AID before and after CD19-CAR T-cell therapy and from five patients with AID after RTX treatment. In addition, non-lymphoid organ biopsies (colon, kidney and gallbladder) from three additional patients with AID after CD19-CAR T-cell therapy were analysed. CD19+ and CD20+ B cells were completely depleted in the lymph nodes after CD19-CAR T-cell therapy, but not after RTX treatment. Plasma cells, T cells and macrophages in the lymph nodes remained unchanged. Follicular structures were disrupted and FDCs were depleted in the lymph nodes after CD19-CAR T-cell therapy, but not after RTX. Non-lymphoid organs were completely depleted of B cells. Discussion This study demonstrates complete B-cell depletion in secondary lymphoid tissues of patients with AIDs following CD19-CAR T-cell therapy combined with standard lymphodepleting therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Bargou, R., Leo, E., Zugmaier, G., Klinger, M., Goebeler, M., Knop, S., Noppeney, R., Viardot, A., Hess, G., Schuler, M., et al. (2008) · Science · doi:10.1126/science.1158545 · Cited by 1,078
Cited by
In vivo CAR T cell generation to treat cancer and autoimmune disease
Hunter, T. L., Bao, Y., Zhang, Y., Matsuda, D., Riener, R., Wang, A., Li, J. J., Soldevila, F., Chu, D. S. H., Nguyen, D. P., et al. (2025) · Science · doi:10.1126/science.ads8473 · Cited by 330
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Furie, R. A., Rovin, B. H., Garg, J. P., Santiago, M. B., Aroca-Martínez, G., Zuta Santillán, A. E., Alvarez, D., Navarro Sandoval, C., Lila, A. M., Tumlin, J. A., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2410965 · Cited by 260
Targeting PD-1 + T cells with chimeric antigen receptors to reduce the HIV reservoir
Ermellino, L., Banga, R., Georgakis, S., Kadzioch, N. P., Procopio, F., Alcaraz-Serna, A., Alfageme-Abello, O., Porret, R., Cecchin, R., Orfanakis, M., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb7602
Metadata
- Authors
- Tur, C., Eckstein, M., Velden, J., Rauber, S., Bergmann, C., Auth, J., Bucci, L., Corte, G., Hagen, M., Wirsching, A., Grieshaber-Bouyer, R., Reis, P., Kittan, N., Wacker, J., Rius Rigau, A., Ramming, A., D'Agostino, M.-A., Hartmann, A., Müller, F., Mackensen, A., Bozec, A., Schett, G., & Raimondo, M. G.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2025-01
- Volume
- 84
- Issue
- 1
- Pages
- 106-114
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W4401664751
- Cited by
- 187
- References
- 3
- FWCI
- 28.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD19-CAR T-cell therapy induces deep tissue depletion of B cells. https://app.cochat.ai/papers/10.1136/ard-2024-226142
- The paper
- Tur, C., Eckstein, M., Velden, J., Rauber, S., Bergmann, C., Auth, J., Bucci, L., Corte, G., Hagen, M., Wirsching, A., Grieshaber-Bouyer, R., Reis, P., Kittan, N., Wacker, J., Rius Rigau, A., Ramming, A., D'Agostino, M.-A., Hartmann, A., Müller, F., . . . Raimondo, M. G. (2025). CD19-CAR T-cell therapy induces deep tissue depletion of B cells. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2024-226142
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.